In order to further explore the mechanism behind the lack of differences in the behavior of the targeted-MB in the tumor models used, we validated CXCR4 expression in the same tumor models with [18F]MCFB, a CXCR4-targeting small-molecule analogue PET imaging agent previously developed by our group [33]. This evidence concerns the gene CXCR4 and neoplasm.